Acquisition of Elsie Biotechnologies is expected to strengthen GSK’s research capabilities in modulating gene expression ...

Data published in the New England Journal of Medicine from Gilead’s Phase IIb MYR204 found the bulevirtide/ pegylated ...

Eli Lilly and Company announced that Anat Ashkenazi has decided to step down as chief financial officer. 1 She will continue ...

In this part of his Pharmaceutical Executive video interview, Brice Challamel, Vice President, AI Products & Platforms, ...

Blue Cross Blue Shield of Massachusetts announced that it is expanding support for LGBTQIA+ members. 1 This includes greater ...

In a majority vote, the Psychopharmacologic Drugs Advisory Committee cited concerns regarding the data presented for MDMA as ...

A similar application was also submitted to the EMA for the expanded use of Prezcobix to treat children aged 6 years and ...

The industry has struggled to recruit talent for years, and the challenge is only getting more difficult. Pharma companies ...

Deployments are often built on the concept that growth comes from new prescribers, which may be limiting their success.

EVERSANA INTOUCH Media’s EVP discusses how the ban may impact the industry and how companies can prepare for it.

Pharmaceutical Executive: What are some of the hurdles making the adoption of VBC difficult? Matthew Hellinger and Ian ...

Medical technology company Becton, Dickinson, and Company (BD) announced that it will acquire Edwards Lifesciences’ Critical ...